Recombinant monoclonal antibody to PTPRC. VHQ/humV1 is a humanized antibody that can be potentially used in the treatment of pancreatic islet cell transplant rejection.
Figure 1 shows that the inhibition of primary MLR by the mAb is dose-dependent in the range of 0.001 and 10 μg/ml.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1135z | Mouse Anti-PTPRC Recombinant Antibody (clone 19C6) | WB, FC, IF, IHC | Mouse IgG2a, κ |
HPAB-0365-CN | Rabbit Anti-PTPRC Recombinant Antibody (HPAB-0365-CN) | ELISA, FC | Rabbit IgG |
HPAB-0366-CN | Human Anti-PTPRC Recombinant Antibody (HPAB-0366-CN) | ELISA, FC | Humanized IgG |
FAMAB-0006-CN | Mouse Anti-PTPRC Recombinant Antibody (clone LT40) | FC | Mouse IgG |
HPAB-M0191-YC | Human Anti-PTPRC Recombinant Antibody (clone M/YC-14) | ELISA, WB | Human IgG |
There are currently no Customer reviews or questions for TAB-242LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.